All News
06.06.2024
Chronic Pain and Pastoralists in Ethiopia
Chronic pain is a significant global health concern and access to pain control is a basic human right. While the burden of chronic pain is well described in high-income countries,… More...
06.06.2024
Launch of Swiss TPH Alumni Network
Since the founding of Swiss TPH in 1943, education and training has been a cornerstone of our activities. Our diverse community of graduates works around the globe in multilateral… More...
31.05.2024
Ministers of Health from Rwanda and Senegal Visit Swiss TPH
Yesterday, Sabin Nsanzimana, Minister of Health from Rwanda and Ibrahima Sy, Ministre de la Santé et de l'Action Sociale from Senegal, visited Swiss TPH. The delegations discussed… More...
31.05.2024
Not Just a Sneeze: Pollen Increase Blood Pressure
Pollen allergies affect an estimated fifth of the world’s population. Researchers from Swiss TPH now found that high pollen concentrations on average increase blood pressure in… More...
31.05.2024
Swiss TPH Annual Report Is Out Now!
The Annual Report 2023 highlights our achievements in improving the health of people worldwide, with a particular focus on drug development for poverty-related diseases and looks… More...
14.05.2024
Hay Fever on the Increase Due to Climate Change
The hay fever situation in Switzerland is deteriorating because of climate change: the hay fever season is becoming longer, pollen concentrations are increasing, and highly… More...
14.05.2024
Heat as a Health Risk: Need for Action to Raise Public Awareness
On behalf of the federal government, Swiss TPH conducted the first nationally representative population survey in Switzerland about heat and its effects on health. The results show… More...
03.05.2024
154 Million Deaths Averted: Contribution of Vaccination over the Past 50 Years
In 1974, the World Health Organization launched its Expanded Programme on Immunization. Now, 50 years later, a study shows that an estimated 154 million deaths have been averted… More...
25.04.2024
CALINA Study Shows Positive Efficacy and Safety Data for a Novel Treatment for Small Babies
Novartis and Medicines for Malaria Venture (MMV) announce positive data from their phase II/III CALINA study, demonstrating that a novel formulation of Coartem®… More...